Which closed-end funds own Cheplapharm Arzneimittel?
6 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $80.5M. Security type: debt security. Country: Germany. CUSIP ZK3492137 · ISIN XS2618867159.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| PTY PIMCO Corporate & Income Opportunity Fund | Multi-Asset | 1.69% | $42.6M | 35,900,000 par | $2.5B | 2.4% discount | Jun 30, 2026 |
| PFN PIMCO Income Strategy Fund II | Taxable Bonds | 1.66% | $12.3M | 10,400,000 par | $742M | 4.9% discount | Jun 30, 2026 |
| PCN PIMCO Corporate & Income Strategy Fund | Taxable Bonds | 1.55% | $13.8M | 11,600,000 par | $886M | 3.3% discount | Jun 30, 2026 |
| PHK PIMCO High Income Fund | High Yield | 0.98% | $9.4M | 7,900,000 par | $952M | 5.4% discount | Jun 30, 2026 |
| PGP PIMCO Global StocksPLUS & Income Fund | Global Equity | 0.76% | $1.1M | 900,000 par | $140M | 6.3% discount | Jun 30, 2026 |
| BGH Barings Global Short Duration High Yield Fund | High Yield | 0.34% | $1.4M | 1,180,000 par | $410M | 9.4% discount | Jun 30, 2026 |
6 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Cheplapharm Arzneimittel | debt security | 2 |
| Cheplapharm Arzneimittel | debt security | 1 |
| Cheplapharm Arzneimittel | debt security | 1 |
| Cheplapharm Arzneimittel | debt security | 1 |
Issuer-level search for “CHEPLAPHARM ARZNEIMITTEL” → · Compare two funds’ portfolios →